News
April 14, 2025--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback